Moderna Inc
U.S. secures 171 million omicron Covid shots ahead of fall vaccination campaign
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Health and Human Services Department has secured 171 million doses of new Covid vaccines that target the omicron […]
Read More
Despite concerns, ESG strategies may become a crowded trade for impact investors – so Vanguard is taking a different track
It’s a fund looking to make money from green investing. The inclusive, actively managed Vanguard Baillie Gifford Global Positive Impact Stock Fund (VBPIX) is an environmental, social and governance product that bundles companies with positive, inclusive and sustainable intentions. “It’s really a fund that’s going to be investing in global equities looking to deliver long-term […]
Read More
FDA authorizes Novavax Covid vaccine for adults as the first new shots in U.S. in more than a year
In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration has authorized Novavax’s two-dose vaccine for adults ages 18 and over, the fourth Covid shot to get emergency approval in the U.S. […]
Read More
Cramer’s lightning round: Gentex is a buy
Chegg Inc: “I don’t know what to make of Chegg. … To me, it seems like the bulls are going to win on this stock.” Moderna Inc: “I think that stock has now come down enough. I would want to own Moderna. I do like Pfizer more.” ONEOK Inc: “Keep it. … I think that’s […]
Read More
FDA panel recommends changing Covid shots to fight omicron this fall
A healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, January 29, 2021. Mike Segar | Reuters The Food and Drug Administration’s panel of independent vaccine experts on Tuesday voted 19 to 2 to […]
Read More
CDC panel recommends Moderna two-dose Covid vaccine for kids ages 6 to 17
The Centers for Disease Control and Prevention is expected to clear Moderna’s two-dose Covid-19 vaccine for kindergartners through high schoolers for public distribution this week after the agency’s panel of independent vaccine experts unanimously voted Thursday to recommend the shots. The committee endorsed Moderna’s vaccine for kids ages 6 to 17 after examining its safety […]
Read More
Moderna to build new vaccine facility in Britain
Jakub Porzycki | NurPhoto | Getty Images U.S. biotech firm Moderna will build a new research and manufacturing center in Britain to develop vaccines against new COVID-19 variants, other respiratory illnesses and help improve readiness for any future pandemics. The facility is expected to start producing shots in 2025 and Britain has made a commitment […]
Read More
Kevin O’Leary names 3 companies to invest in: These are ‘not going to zero’
It’s a tough year to be invested in stocks, with the stock market experiencing a seemingly never-ending cycle of gyrations. Major U.S. indexes fell last week, with the Dow Jones Industrial Average ending the week at 29,888.78 — just a day after it dipped below the key 30,000 level for the first time since January […]
Read More
CDC advisors recommend Covid vaccines for children as young as 6 months
A child is administered a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine. Mayela Lopez | Reuters The Centers for Disease Control and Prevention’s independent vaccine experts on Saturday backed Pfizer’s and Moderna’s Covid-19 shots for children as young as 6 months. The CDC committee voted unanimously to recommend the shots for use in […]
Read More
Stocks making the biggest moves midday: Seagen, Moderna, Utz, Kroger and more
The Kroger supermarket chain’s headquarters is shown in Cincinnati, Ohio. Lisa Baertlein | Reuters Check out the companies making headlines in midday trading Friday. Seagen — Shares of the biotech company surged more than 16.1% following a Wall Street Journal report that pharmaceutical company Merck is considering buying Seagen. The report, citing people familiar with […]
Read More